Anastrozole Use in Men Receiving Testosterone Therapy
Anastrozole (Arimidex) use in men receiving testosterone therapy is off-label for estrogen-management and is not supported by a guideline dosing regimen for hypogonadism on testosterone (TRT). [1]
FDA-Approved Dosing for Anastrozole
The FDA-approved dosing for anastrozole (Arimidex) is 1 mg by mouth once daily for hormone receptor–positive breast cancer in postmenopausal women. [2]
Evidence for Dosing in Male Populations
In a retrospective chart review of hypogonadal, subfertile men, anastrozole 1 mg daily was administered for 5 months with reductions in estradiol reported. [3]
In a randomized controlled trial of older men with low testosterone, anastrozole 1 mg daily was administered for 12 months versus placebo. [4]
Guideline Recommendations on Aromatase Inhibitor Co-Administration During TRT
The Endocrine Society testosterone guideline focuses on TRT initiation and monitoring and does not provide an aromatase inhibitor (AI) dosing protocol for routine management of estradiol in men on TRT. [1]
The AUA male infertility guideline includes aromatase inhibitors as potential options for infertile males with low serum testosterone, but it does not provide a testosterone-therapy dosing regimen for anastrozole. [5]
Dosing Strategy When Estradiol Excess Occurs on TRT
A testosterone-related “start dose” for anastrozole in men with hypogonadism on TRT is not established by major guidelines, so dosing is individualized based on estradiol concentrations and clinical response. [1]
Initiation and Monitoring Considerations
Estradiol monitoring is typically paired with clinical assessment of estrogen-excess symptoms and follow-up laboratory testing after any dosing change. [1]
Safety Considerations With Estradiol Suppression
Because pharmacologic aromatase inhibition markedly suppresses estradiol in men, therapy can be associated with clinically relevant risks from low estradiol exposure, so dose adjustment requires laboratory-guided titration rather than fixed empiric TRT-adjunct dosing. [4]
Practical Dosing Summary From Available Published Regimens
The only clearly documented oral regimen in male studies commonly available in clinical literature is anastrozole 1 mg by mouth once daily. [3], [4]
No guideline-supported dosing regimen exists specifically for men with hypogonadism on TRT, so any lower-frequency or reduced-dose approach used in practice is off-guideline and should be guided by estradiol results and symptoms. [1]
References for Male Dosing in the Absence of TRT-Specific Protocols
When male dosing is needed in the absence of a TRT-specific guideline, the closest supported approach from male studies is 1 mg daily with subsequent reassessment of estradiol and symptoms to guide further adjustment. [3], [4]